NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jane Street Group LLC0.10%92,753$127.07kInstitution
Lion Point Capital LP0.09%81,151$111.18kInstitution
Morgan Stanley0.05%46,394$63.56kInstitution
Old Mission Capital LLC 10.03%28,431$38.95kInstitution
Millennium Management LLC0.02%20,308$27.82kInstitution
Rhumbline Advisers0.01%5,204$7.13kInstitution
Gamma Investing LLC0.00%1,073$1.47kInstitution
Ubs Group Ag0.00%947$1.30kInstitution
Farther Finance Advisors LLC0.00%10$13.70Institution
Sageview Advisory Group LLC0.00%1$1.37Institution

1 of 2

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.29%0.00%
AGEN7.16%92.84%Net BuyingNet Buying
ACOG45.51%17.62%Net BuyingNet Buying
EQ55.81%22.62%Net SellingNet Selling
SGMO15.03%7.68%Net SellingNet Selling

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.29% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 99.71% retail investors. Jane Street Group LLC is the largest individual Innate Pharma Sa shareholder, owning 92,753.00 shares representing 0.10% of the company. Jane Street Group LLC's Innate Pharma Sa shares are currently valued at $127.07k.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.